Precise medicated diet food therapy product for rheumatoid arthritis, and preparation method thereof

Abstract

The invention provides a precise medicated diet food therapy product for rheumatoid arthritis, and a preparation method thereof. The product is prepared from the following substances in parts by mass: 1-20 parts of Symphytum officinale L., 1-15 parts of moringa oleifera leaves, 1-15 parts of lindera aggregata leaves, 1-15 parts of sophora flower buds, 1-15 parts of herba cepbalanoplosis segeti, 1-15 parts of pawpaw, 1-20 parts of coix seeds, 1-15 parts of zaocys dhumnade, 1-15 parts of purslane, 1-10 parts of cinnamon, 1-10 parts of liquorice, 0.1-1 part of chitosan oligosaccharide and 0.1-1.0 part of hyaluronic acid. The product provided by the invention is a precise medicinal and edible product with clear main medicinal components and relatively clear action targets, can well meet the clinical requirements of rheumatoid arthritis resistance and people requirements, can effectively treat rheumatoid arthritis, and does not have any adverse toxic or side effect in the clinical observation process.

Description

technical field [0001] The invention belongs to the technical field of medicated diet therapy products, and in particular relates to a precise medicated diet therapy product for rheumatoid arthritis and a preparation method thereof. Background technique [0002] RA is one of the major disabling diseases, with an average prevalence of about 1% worldwide, and about 4 million patients in my country, with a prevalence of 0.32% to 0.34%. At present, there is no specific drug for the treatment of RA, and the conventional treatment methods are only to relieve pain, reduce inflammation, slow down or stop joint destruction, and improve the health and mobility of patients. Clinically commonly used drugs include non-steroidal anti-inflammatory drugs, chronic antirheumatic drugs, immunosuppressants, corticosteroids, and biological products. [0003] Clinically, as a chronic systemic inflammatory disease, once rheumatoid arthritis occurs, patients will suffer from joint deformity, symme...

AI Technical Summary

Problems solved by technology

At present, the commonly used Chinese patent medicines for the treatment of rheumatoid arthritis include Tongluo Kaibi Tablets, Jinwugutong Capsules, Jintiange Capsules, Panlong Qili Tablets, Fufang Xiawu Tablets, Zhengqing Fengtongning Tablets, etc., but these are all Belongs to pharmaceutical products, there is currently no medicine and food homologous products for the prevention of rheumatoid arthritis

Images